PQE-GROUP
18.7.2022 14:17:10 CEST | Business Wire | Press release
The first half of 2022 has closed highly positively for PQE Group , the global women-owned quality consulting company for Lifesciences. The Italian parent Group, after having concluded 2021 with + 20% increase in revenues, confirms its development plan with the announcement of two acquisitions and a new legal entity in Melbourne (Australia) and a new office in Buenos Aires (Argentina).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220718005086/en/
As stated at the beginning of 2022, most of the global staff development plan has been implemented with almost 400 new hires around the world, 200 of which are located in Italy or the US, followed by the PQE Group Mexican Affiliate.
With a strong focus on the United States and Latin America, the company managed by Gilda D'Incerti has started the acquisition process of two firms, announcing the affiliation of United Pharma Technologies Inc. , a service company based in New Jersey, and Quintian Pharma , based in Malta.
The M&A model of the company embraces the concept of a Federation rather than a classic acquisition, which aims to exchange shares with different entities in local markets all over the world to create close knit alliances, allowing to scale up projects’ staff and capabilities faster and more efficiently.
“In our unique and different approach to M&A activities, we aim to engage with entrepreneurs and not just companies, bringing business development ideas to the table and acting as a whole organization by sharing the same vision, mission and network.” – Danilo Neri, Vice President Executive and Board Equity Partner at PQE Group.
Quintian Pharma , administered by Claude Vella Bonanno , is committed to providing services and support to the pharmaceutical industry, following all EU directives on new products. PQE Group will join the Board as main shareholder (51%) and support the strategic growth of the consulting agency specialized in applying EU Pharmacovigilance standards to clients in the Middle East.
United Pharma Technologies Inc., a service agency based in New Jersey – USA, was founded in 2014 and is currently managed by Vasantha Madasu , who will join PQE Group as a local partner in the US and Mexican affiliates and has been named Chief Talent Officer for the Americas.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220718005086/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2026 Esri User Conference to Focus on Creating a More Intelligent World with GIS25.6.2026 14:00:00 CEST | Press release
More Than 18,000 Attendees Expected for World's Largest GIS Conference in San Diego The 2026 Esri User Conference will be held from July 13 to 17 in San Diego, California. This year's theme is "GIS—Creating a more intelligent world." Jack Dangermond, president and founder of Esri, and Kristine Tompkins, president and cofounder of Tompkins Conservation, will be the keynote speakers in the Plenary Session. Esri, the global leader in geographic information system (GIS) technology, today announced speakers and the conference theme for the 2026 Esri User Conference. The conference will be held from July 13 to 17 at the San Diego Convention Center in San Diego, California. This year's theme of "GIS—Creating a more intelligent world" will emphasize how GIS turns the science of "where" into shared understanding and coordinated action—at the scale of communities, enterprises, and the planet. Kristine Tompkins, president and cofounder of Tompkins Conservation, will join Esri president Jack Dange
Copeland Releases FY2025 Global Impact Report Highlighting Energy Efficiency, Safety and Innovation Progress25.6.2026 14:00:00 CEST | Press release
Scope 1 and Scope 2 greenhouse gas emissions declined nearly 20%1Near-term reduction targets validated by the Science Based Targets InitiativeGlobal Total Recordable Incident Rate improved to 0.21, outperforming the industry average by over 90% Copeland, a global leader in compression technologies and controls solutions, has released its second annual Global Impact Report. The report highlights the company’s Fiscal Year 2025 (FY25) progress across environmental sustainability, workplace safety and community impact, guided by its Purpose, Performance and People pillars. Copeland has advanced its sustainability commitments through three strategic areas of focus: Performance-Driven Decarbonization: Copeland reduced Scope 1 and Scope 2 greenhouse gas emissions by 20% year-over-year, advancing toward its Science Based Targets initiative (SBTi)-validated goal of a 55% absolute reduction by FY33, using FY23 as a baseline.2 Renewable energy procurement and onsite solar generation accounted for
ExaGrid Wins 4 Industry Awards at the Storage Awards25.6.2026 14:00:00 CEST | Press release
ExaGrid has won 11 awards for its Tiered Backup Storage so far in 2026 ExaGrid®, the world’s largest independent backup storage vendor providing Tiered Backup Storage with the most Comprehensive Security and AI-Powered Retention Time-Lock for Ransomware Recovery, today announced that the company was honored with four industry awards during the 23rd annual Storage Awards ceremony, “The Storries,” held in London on June 18, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625584191/en/ The ExaGrid team headed to the stage four times throughout the Storage Awards ceremony in London to accept awards for ExaGrid Tiered Backup Storage. Photo courtesy of Storage Awards. ExaGrid was named Data Protection Company of the Year, Immutable Storage Company of the Year, Storage Company of the Year, andjointly received the Storage Solution of the Year - Corporate award with key channel partner Convergent Technology. ExaGrid continues
SUTEL Deploys Tecnotree Platform to Modernize Mobile Prepaid Registration and Strengthen Digital Security and Trust in Costa Rica25.6.2026 13:26:00 CEST | Press release
New Tecnotree platform will provide a faster, safer, and more accessible registration process for prepaid mobile users The Superintendence of Telecommunications (SUTEL) is advancing the modernization of Costa Rica’s Mobile Prepaid Registration System through the implementation of a new technological platform provided by Tecnotree designed to strengthen user identification processes, enhance regulatory compliance, and improve the overall customer experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625307287/en/ This initiative is part of SUTEL’s ongoing efforts to promote digital transformation within the telecommunications sector while reinforcing security, transparency, and trust in digital communications across the country. The new Tecnotree platform incorporates advanced identity verification mechanisms, biometric authentication capabilities, and fraud prevention tools that will enable a more efficient and secur
MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b25.6.2026 13:00:00 CEST | Press release
The appointments position MRM Health for its next key clinical, partnering and financing milestones MRM Health, a clinical-stage biotech developing microbiome-based therapies for immune-mediated diseases, today announced the appointment of two experienced industry leaders to its Board of Directors as the Company enters a pivotal phase of growth. With its lead program, MH002, in Phase 2b clinical development, recent FDA Fast Track designation and a €55 million Series B financing, MRM Health is strengthening its Board to support the Company through its next clinical, strategic and financing milestones. Michel Detheux, PhD, has been appointed Chairman of the Board of Directors, taking over from Werner Cautreels. Prof. Dr. med. Hans-Jürgen Wörle joins the Board as an Independent Director. “MRM Health is entering a pivotal phase, with MH002 advancing into Phase 2b clinical development and significant momentum across the business. The appointments of Michel and Hans-Jürgen significantly stre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom